0 valutazioniIl 0% ha trovato utile questo documento (0 voti)
62 visualizzazioni30 pagine
Drug Interactions can be defined as the modifications of the effects of one drug by the prior or concomitant of another drug (poly-pharmacy) a drug interaction is a situation in which a substance affects the activity of a drug, i.e. The effects are increased or decreased, or they produce a new effect that neither produces on its own.
Drug Interactions can be defined as the modifications of the effects of one drug by the prior or concomitant of another drug (poly-pharmacy) a drug interaction is a situation in which a substance affects the activity of a drug, i.e. The effects are increased or decreased, or they produce a new effect that neither produces on its own.
Drug Interactions can be defined as the modifications of the effects of one drug by the prior or concomitant of another drug (poly-pharmacy) a drug interaction is a situation in which a substance affects the activity of a drug, i.e. The effects are increased or decreased, or they produce a new effect that neither produces on its own.
Satgas Farmasi IDAI Topics on Drug Interactions Definition Types of drug interaction Pharmaceutical interaction Pharmacodynamic interaction Pharmacokinetic interaction Effects of drug interaction Definition Drug interaction can be defined as the modifications of the effects of one drug by the prior or concomitant of another drug (poly-pharmacy) A drug interaction is a situation in which a substance affects the activity of a drug, i.e. the effects are increased or decreased, or they produce a new effect that neither produces on its own. Occurence of drug interactions In Vitro In Vivo (in patients) : Clinically expected or unexpected Clinically observed or undetected Clinical effect can be severe or light In Vitro drug interactions Drugs Interactant Result Ceftriaxone sodium Lactated Ringer's solution Ca-Ceftriaxone precipitate Daptomycin Dextrose solution Daptomycin precipitate Daptomycin 0.9% saline solution Lactated Ringer's solution Compatible Piperacillin-tazobactam Acyclovir Particle formation Amphotericin B Flocculent Mitomycin Blue colour Theophylline Cefepime Cefepime degrades up to 25% David W. Newton (2009) Am J Health-System Pharm. 66(4):348-357 Thilo Bertsche et al (2008) Am J Health-Syst Pharm. 65(19):1834-1840 Treatment outcome is the NET result of interaction the patient, environment, drug and disease Pharmacokinetics Pharmacodynamics Adverse Effects/ Toxicity Clinical Efficacy Age Sex Genetic / ethnic Drug interaction Body weight Environment Nutritional status Disease state Source of viability in Drug Response Risk Factors for Drug Interactions High Risk Patients Elderly, young, very sick, multiple disease Multiple drug therapy Renal, liver impairment High Risk Drugs Narrow therapeutic index drugs (steroid, rifampicin, quinidin) Recognized enzyme inhibitors or inducers Pharmaceutical Interactions Interactions that occur prior to systemic administration. For example incompatibility between two drugs mixed in an IV fluid. These interactions can be physical (e.g. with a visible precipitate) or chemical with no visible sign of a problem Drug Interactions before drug administration Phenytoin precipitates in dextrose end of IV. Intravesicular amphotericim precipitates in Saline bladder wall necrosis Gentamicin bind piperacillin loss of antibiotic effect Pharmacodynamic interaction Definition interaction that one drug may cause changes in another drug action, effect or response without PK alteration Pharmacodynamic interaction could result in either Additive effect Synergistic effect Antagonistic effect Pharmacodynamic interaction can happen at these levels Level of drug action Level of drug effect Level of drug response At this level, it could be called Physiological interaction Pharmacodynamic Interactions One drug causes a change in patient response to another drug without altering that drugs pharmacokinetics Eg increase toxicity of digoxin caused by diuretic induced hypokalaemia Additive effects of alcohol and benzodiazepines Beta-blocker given with beta-agonist What is Pharmacokinetics (PK)? Means movement of drugs Study of the relationship between dose, amount of drug in the body and therapeutic or toxic effects of a drug Pharmacokinetic data help us understand: dose and schedule (once a day vs. twice a day, etc) dose adjustments due to drug interactions and other issues. How Do Drug Interactions Happen? They occur due to changes in the pharmacokinetics of a drug Changes in the absorption, distribution, metabolism and excretion (ADME) of a drug Toxic Effective Ineffective 0 6 12 18 24 TIME C o n c e n t r a t i o n Processes that Determine Drug PK Absorption: how the drug enters the blood The amount of acid in stomach or amount of food changes the amount of drug absorbed This is why some drugs must be taken with or without food or can not be taken with antacids Distribution: how the drug travels in the blood and how it goes into and out of other areas of the body Metabolism: how the body changes a drug usually in intestine and liver Drug Elimination: how the body gets the drug out: via kidneys through urine or via liver though stool http://www.thebody.com/content/art875.html Pharmacokinetic interaction These interactions are characterized by the alteration of the PK or disposition (ADME) of one drug by another. Change in absorption Change in distribution Change in Metabolism Change in Excretion Important PK interactions are those associated with Altered drug metabolism Drug transporters Protein binding Altered Absorption Change in gastrointestinal pH Ketoconazole needs acidic conditions in gut Drug binding in GI tract (E.g. tetracycline and calcium) Change in gastrointestinal flora Antibiotics with digoxin (increased toxicity) Change in gastrointestinal motility (metoclopramide) Drug induced mucosal damage (antineoplastic agents) Displaced protein binding Phenytoin displaced by aspirin / sulfonamide Altered metabolism (liver enzyme CYP450 family) In the GI Tract Sucralfate, antacids, and oral iron preparations Omeprazole, lansoprazole, H2-antagonists Didanosine (given as a buffered tablet) Cholestyramine Block absorption of quinolones, tetracycline, and azithromycin Reduce absorption of ketoconazole, delavirdine Reduces ketoconazole absorption Binds raloxifene, thyroid hormone, and digoxin Pharmacokinetic Drug Interactions : Absorption Alteration Action Drug binding in GI tract Iron may chelate ciprofloxacin, resulting in decreased absorption GI motility Increased GI motility caused by metoclopramide may decrease cefprozil absorption GI pH GI alkalinization by omeprazole may decrease absorption of ketoconazole GI flora Decreased GI bacterial flora caused by an antibiotic admin could decrease bacterial production of vitamin K augmenting anticoagulant effect of warfarin Drug metabolism in wall of intestine MAO in the wall of GI tract may be inhibited by MAO inhibitors resulting in increased blood pressure to phenylephrine PK interaction associated with drug transporters Transporters Playing Key Roles in Drug Absorption and Excretion Important drug transporters P-glycoproteins (PgP) very important for excretion processes Other transporters : Albumin Interaction usually result in Inhibit function of transporters And inhibit drug excretion And finally cause AUC of a drug to increase or more drug in the body Drug Metabolism Many drug interactions are due to changes in drug metabolism: How the body changes a drug (usually in intestines and liver) Breaks drug down to make it easer to pass into urine or stool Main system involved in drug metabolism interactions is CYP P450 enzymes found in liver and intestines Drug Interactions Via Liver Interactions that happen through CYP enzymes are either based on enzyme induction or inhibition Induction: Drug A induces the body to produce more of an enzyme which metabolized Drug B . This reduces the amount of drug B, which may lead to loss of drug Bs effectiveness Inhibition: Drug A inhibits the production of enzymes to metabolize Drug B. This increases the amount of Drug B in the body and could lead to an overdose or toxic effects Drug administration Absorption Enteric transport Enteric metabolism Distribution Intravascular space Extravascular space Protein binding Metabolism Hepatic influx transport Phase I metabolism Phase II metabolism Biliary excretion Efflux transport Intestinal excretion Renal excretion Efflux transport Nature Reviews/ Cancer Drug Excretion Definition The removal of a drug molecule from the body without chemical modification. Generally in urine, but occasionally in bile , intestine. Processes involved in renal excretion: 1 Filtration Passive process (Pressure driven) 20% of plasma volume is filtered Small molecules - Yes Large molecules No Most proteins not filtered. Drugs which are extensively protein bound will also not be filtered. Acids Furosemide Penicillins Probenecid Bases Quinine Quaternary ammonium salts Probenecid and penicillins share same mechanism. - Probenecid competes with penicillins. -Penicillin clearance reduced. Processes involved in renal excretion: 2 Active secretion Excretion Interaction Change in renal blood flow Methotrexate and NSAIDs NSAIDS can decrease renal blood flow by inhibition of renal prostaglandins. Reduced clearance of MTX and active (toxic) metabolite Onset of drug interaction It may be seconds up to weeks for example in case of enzyme induction, it needs weeks for protein synthesis, while enzyme inhibition occurs rapidly. The onset of action of a drug may be affected by the half lives of the drugs e.g., cimitidine inhibits metabolism of theophylline. Cimitidine has a long half life, while, theophylline has a short one. When cimitidine is administered to a patient regimen for Theophylline, interaction takes place in one day. Effect of Drug interaction Therapeutic drug interaction could be used in 2 objectives 1. To produce synergistic therapeutic effects Examples are found by several antibiotic combinations Penicillin-Sreptomycin Penicillin-Probenecid Sulfa-trimethoprim 2. To detoxify or lower toxic effects Examples are those antidotes of certain toxic agents Outcomes of drug interactions 1) Loss of therapeutic effect 2) Toxicity 3) Unexpected increase in pharmacological activity 4) Beneficial effects e.g additive & potentiating (intended) or antagonism (unintended). 5) Chemical or physical interaction e.g I.V incompatibility in fluid or syringes mixture * Prevention of drug interaction 1) Monitoring therapy and making adjustments 2) Monitoring blood level of some drugs with narrow therapeutic index e.g., digoxin, anticancer agentsetc 3) Monitoring some parameters that may help to characterize the the early events of interaction or toxicity e.g., with warffarin administration, it is recommended to monitor the prothrombin time to detect any change in the drug activity. 4) Increase the interest of case report studies to report different possibilities of drug interaction Thanks